Murphy SA - Search Results

1

Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.

Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, Deenadayalu N, Murphy SA, Grip LT, Betcher JM, Duggal A, Dave J, Shi M, Mercuri M, Antman EM, Braunwald E; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. Among authors: murphy sa. Stroke. 2014 Aug;45(8):2372-8. doi: 10.1161/STROKEAHA.114.006025. Epub 2014 Jun 19. Stroke. 2014. PMID: 24947287 Clinical Trial.

2

Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.

Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Gibson CM, et al. Am Heart J. 1999 Jun;137(6):1179-84. doi: 10.1016/s0002-8703(99)70380-7. Am Heart J. 1999. PMID: 10347349

3

Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.

Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Gibson CM, et al. J Am Coll Cardiol. 1999 Nov 1;34(5):1403-12. doi: 10.1016/s0735-1097(99)00397-6. J Am Coll Cardiol. 1999. PMID: 10551685

4

Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).

Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CM. Llevadot J, et al. Am J Cardiol. 2000 Jun 15;85(12):1409-13. doi: 10.1016/s0002-9149(00)00786-4. Am J Cardiol. 2000. PMID: 10856384

5

Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.

Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS. Srinivas VS, et al. Am Heart J. 2001 Jul;142(1):29-36. doi: 10.1067/mhj.2001.116068. Am Heart J. 2001. PMID: 11431653 Clinical Trial.

6

Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes.

Cohen M, Antman EM, Murphy SA, Radley D. Cohen M, et al. Among authors: murphy sa. Am Heart J. 2002 Jan;143(1):63-9. doi: 10.1067/mhj.2002.119767. Am Heart J. 2002. PMID: 11773913 Clinical Trial.

7

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Among authors: murphy sa. Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a. Circulation. 2002. PMID: 11956114

8

Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.

Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: murphy sa. Circulation. 2002 Apr 23;105(16):1909-13. doi: 10.1161/01.cir.0000014683.52177.b5. Circulation. 2002. PMID: 11997276 Clinical Trial.

9

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes.

Becker RC, Spencer FA, Gibson M, Rush JE, Sanderink G, Murphy SA, Ball SP, Antman EM; TIMI 11A Investigators. Becker RC, et al. Among authors: murphy sa. Am Heart J. 2002 May;143(5):753-9. doi: 10.1067/mhj.2002.120774. Am Heart J. 2002. PMID: 12040334

10

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.

Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Antman EM, et al. Eur Heart J. 2002 Jun;23(12):928-33. doi: 10.1053/euhj.2001.2964. Eur Heart J. 2002. PMID: 12069446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

662 results

Search Page